![](/images/general/no_picture/200_user.png)
Christine T Mui
Examiner (ID: 15280, Phone: (571)270-3243 , Office: P/1797 )
Most Active Art Unit | 1797 |
Art Unit(s) | 1777, 1709, 1797, 1774 |
Total Applications | 1416 |
Issued Applications | 1043 |
Pending Applications | 77 |
Abandoned Applications | 296 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5252795
[patent_doc_number] => 20070134251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Assays and methods using biomarkers'
[patent_app_type] => utility
[patent_app_number] => 11/542527
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26638
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542527
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542527 | Assays and methods using biomarkers | Oct 2, 2006 | Abandoned |
Array
(
[id] => 5193488
[patent_doc_number] => 20070081972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Polymer-based delivery system for immunotherapy of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/527746
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20070081972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527746
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527746 | Polymer-based delivery system for immunotherapy of cancer | Sep 25, 2006 | Abandoned |
Array
(
[id] => 4771394
[patent_doc_number] => 20080057052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/535397
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6781
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535397 | Compositions and methods for treating cancer | Sep 25, 2006 | Issued |
Array
(
[id] => 5106572
[patent_doc_number] => 20070065449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab)'
[patent_app_type] => utility
[patent_app_number] => 11/522687
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12820
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522687
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522687 | Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab) | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5585013
[patent_doc_number] => 20090104215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Methods and compositions for modulating tumor cell activity'
[patent_app_type] => utility
[patent_app_number] => 11/991459
[patent_app_country] => US
[patent_app_date] => 2006-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 6796
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991459
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991459 | Methods and compositions for modulating tumor cell activity | Sep 12, 2006 | Issued |
Array
(
[id] => 5215636
[patent_doc_number] => 20070104717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Compositions and methods for detecting and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/519248
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 36432
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519248 | Compositions and methods for detecting and treating cancer | Sep 11, 2006 | Abandoned |
Array
(
[id] => 5135977
[patent_doc_number] => 20070077606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Methods and compositions to correlate trichomonas infection with prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/519708
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6817
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519708
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519708 | Methods and compositions to correlate Trichomonas infection with prostate cancer | Sep 11, 2006 | Issued |
Array
(
[id] => 5367162
[patent_doc_number] => 20090304721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/065832
[patent_app_country] => US
[patent_app_date] => 2006-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 64914
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304721.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065832 | TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES | Sep 6, 2006 | Abandoned |
Array
(
[id] => 5142414
[patent_doc_number] => 20070004630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology'
[patent_app_type] => utility
[patent_app_number] => 11/517599
[patent_app_country] => US
[patent_app_date] => 2006-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 19985
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004630.pdf
[firstpage_image] =>[orig_patent_app_number] => 11517599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/517599 | Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology | Sep 4, 2006 | Issued |
Array
(
[id] => 5182529
[patent_doc_number] => 20070053873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'CANINE TUMOR TREATMENT METHOD, PHARMACEUTICAL FORMULATION APPLIED THERETO, AND METHOD OF CRYOGENICALLY PRESERVING CELLS USED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 11/465892
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5720
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11465892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/465892 | CANINE TUMOR TREATMENT METHOD, PHARMACEUTICAL FORMULATION APPLIED THERETO, AND METHOD OF CRYOGENICALLY PRESERVING CELLS USED THEREWITH | Aug 20, 2006 | Abandoned |
Array
(
[id] => 5107676
[patent_doc_number] => 20070066554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Immunostimulatory nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/507079
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 55659
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11507079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/507079 | Immunostimulatory nucleic acids | Aug 17, 2006 | Abandoned |
Array
(
[id] => 217271
[patent_doc_number] => 07612181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Dual variable domain immunoglobulin and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/507050
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 56779
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/612/07612181.pdf
[firstpage_image] =>[orig_patent_app_number] => 11507050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/507050 | Dual variable domain immunoglobulin and uses thereof | Aug 17, 2006 | Issued |
Array
(
[id] => 4692739
[patent_doc_number] => 20080085510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'HUMAN RON-RELATED GENE VARIANT ASSOCIATED WITH CANCERS'
[patent_app_type] => utility
[patent_app_number] => 11/465308
[patent_app_country] => US
[patent_app_date] => 2006-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 6379
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11465308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/465308 | Human Ron-related gene variant associated with cancers | Aug 16, 2006 | Issued |
Array
(
[id] => 5086078
[patent_doc_number] => 20070276129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Modular molecular clasps and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/505630
[patent_app_country] => US
[patent_app_date] => 2006-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19280
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20070276129.pdf
[firstpage_image] =>[orig_patent_app_number] => 11505630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/505630 | Modular molecular clasps and uses thereof | Aug 16, 2006 | Abandoned |
Array
(
[id] => 4792132
[patent_doc_number] => 20080293106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Method For the Mass Production of Immunoglobulin Fc Region Deleted Initial Methionine Residues'
[patent_app_type] => utility
[patent_app_number] => 12/063379
[patent_app_country] => US
[patent_app_date] => 2006-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14809
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063379 | Method for the mass production of immunoglobulin Fc region deleted initial methionine residues | Aug 15, 2006 | Issued |
Array
(
[id] => 5106590
[patent_doc_number] => 20070065467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Immunostimulatory nucleic acid molecules for activating dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 11/503377
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18097
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503377 | Immunostimulatory nucleic acid molecules for activating dendritic cells | Aug 10, 2006 | Abandoned |
Array
(
[id] => 103145
[patent_doc_number] => 07723500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Immunostimulatory nucleic acid molecules'
[patent_app_type] => utility
[patent_app_number] => 11/503483
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21745
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723500.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503483 | Immunostimulatory nucleic acid molecules | Aug 10, 2006 | Issued |
Array
(
[id] => 5050882
[patent_doc_number] => 20070031427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/496457
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13495
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496457 | Cancerous disease modifying antibodies | Jul 30, 2006 | Issued |
Array
(
[id] => 579040
[patent_doc_number] => 07456258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/496392
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12458
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/456/07456258.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496392 | Cancerous disease modifying antibodies | Jul 30, 2006 | Issued |
Array
(
[id] => 5050880
[patent_doc_number] => 20070031425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/496390
[patent_app_country] => US
[patent_app_date] => 2006-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11981
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496390 | Cancerous disease modifying antibodies | Jul 30, 2006 | Issued |